The Government of India, through the National Pharmaceutical Pricing Authority (NPPA), has capped the trade margin at 30% on 137 anti-cancer medicines. The aim is to make cancer treatment more affordable for patients.
Patients and partners with questions about the revised prices are welcome to speak to their doctor, pharmacist or hospital.
Source: NPPA Order S.O. 5690(E), The Gazette of India, 17 October 2026.
Synergy Division offers innovative and reliable hospital care solutions that help healthcare professionals manage critical patient needs. With a strong focus on specialised therapies and quality-driven pharmaceutical products, our division aims to enhance treatment outcomes across hospital and acute care settings. Synergy is committed to improving results by providing reliable, accessible, and trusted therapies that address the evolving needs of modern healthcare.
View by-